XML 29 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCK-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Nov. 02, 2019
Nov. 03, 2018
Nov. 02, 2019
Nov. 03, 2018
Oct. 28, 2017
Feb. 02, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       1 year 3 years  
Share-based Payment Arrangement, Expense $ 2,351 $ 4,476 $ 13,622 $ 20,693    
Share-based Payment Arrangement, Expense, Tax Benefit     3,600 5,500    
Cost of Sales [Member]            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Share-based Payment Arrangement, Expense 900 1,100 $ 2,800 3,000    
Performance Awards Member            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period     26      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 15,700   $ 15,700      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 352   352     352
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 101.27   $ 101.27     $ 90.66
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     $ 109.54      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition     2 years      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     194      
Share-based Payment Arrangement, Expense $ (2,143) $ 1,791 $ (615) $ 10,662    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 99.57      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     349      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     $ 75.83      
Deferred and Restricted Stock (Deferred Awards) Member            
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period     44      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $ 24,500   $ 24,500      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 391   391     299
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 99.29   $ 99.29     $ 99.98
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value     $ 112.20      
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition     1 year 10 months 24 days      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     256      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 103.18      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     120      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     $ 104.53